Skip to content
Screener

Immunovant, Inc. IMVT Q1 2027 earnings

Reported August 6, 2026 · Before market open

Revenue$7.1MIn line
EPS-$0.75Miss by $0.12
Revenue estimate$7.1M
EPS estimate-$0.63

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$7.1M
EPS estimate-$0.73

FAQ

When did Immunovant, Inc. report Q1 2027 earnings?
Immunovant, Inc. (IMVT) reported Q1 2027 earnings on August 6, 2026 before market open.
What were Immunovant, Inc.'s Q1 2027 revenue and EPS?
Immunovant, Inc. reported revenue of $7.1M and eps of $-0.75 for Q1 2027.
Did Immunovant, Inc. beat estimates in Q1 2027?
Revenue beat the consensus estimate of $7.1M by -. EPS missed the consensus estimate of $-0.63 by $0.12.
How did Immunovant, Inc.'s Q1 2027 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 25.0% from $-0.60.
Where can I find Immunovant, Inc.'s Q1 2027 SEC filings?
You can read the 8-K earnings release (0001764013-26-000100) and the 10-Q periodic report (0001764013-26-000101) directly on SEC EDGAR. The filing index links above go to sec.gov.